JP2024516621A5 - - Google Patents

Info

Publication number
JP2024516621A5
JP2024516621A5 JP2023565183A JP2023565183A JP2024516621A5 JP 2024516621 A5 JP2024516621 A5 JP 2024516621A5 JP 2023565183 A JP2023565183 A JP 2023565183A JP 2023565183 A JP2023565183 A JP 2023565183A JP 2024516621 A5 JP2024516621 A5 JP 2024516621A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
group
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023565183A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516621A (ja
JP7868811B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025614 external-priority patent/WO2022226102A1/en
Publication of JP2024516621A publication Critical patent/JP2024516621A/ja
Publication of JP2024516621A5 publication Critical patent/JP2024516621A5/ja
Application granted granted Critical
Publication of JP7868811B2 publication Critical patent/JP7868811B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023565183A 2021-04-21 2022-04-20 イヌ細胞傷害性tリンパ球関連タンパク質4(ctla-4)に対するイヌモノクローナル抗体 Active JP7868811B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163177692P 2021-04-21 2021-04-21
US63/177,692 2021-04-21
PCT/US2022/025614 WO2022226102A1 (en) 2021-04-21 2022-04-20 Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4)

Publications (3)

Publication Number Publication Date
JP2024516621A JP2024516621A (ja) 2024-04-16
JP2024516621A5 true JP2024516621A5 (cg-RX-API-DMAC7.html) 2025-04-08
JP7868811B2 JP7868811B2 (ja) 2026-06-02

Family

ID=83723402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565183A Active JP7868811B2 (ja) 2021-04-21 2022-04-20 イヌ細胞傷害性tリンパ球関連タンパク質4(ctla-4)に対するイヌモノクローナル抗体

Country Status (5)

Country Link
US (2) US12110331B2 (cg-RX-API-DMAC7.html)
EP (1) EP4326324A4 (cg-RX-API-DMAC7.html)
JP (1) JP7868811B2 (cg-RX-API-DMAC7.html)
CA (1) CA3216131A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022226102A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4326324A4 (en) * 2021-04-21 2026-03-25 Univ Pennsylvania Canine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte-Associated Protein 4 (CTLA-4)
CN120265660A (zh) * 2023-04-28 2025-07-04 宾夕法尼亚大学董事会 新型cd19靶向多肽和cd19定向免疫疗法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA314534A (en) * 1931-08-25 The United States Gypsum Company Roof or floor
CA2469833C (en) * 2001-12-21 2008-05-20 Idexx Laboratories, Inc. Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
WO2009126730A2 (en) * 2008-04-09 2009-10-15 The Trustees Of The University Of Pennsylvania Canine single chain fragment variable antibody libraries and uses thereof
AU2020312686B2 (en) * 2019-07-15 2026-07-30 Intervet International B.V. Caninized antibodies against canine CTLA-4
EP4326324A4 (en) * 2021-04-21 2026-03-25 Univ Pennsylvania Canine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte-Associated Protein 4 (CTLA-4)

Similar Documents

Publication Publication Date Title
JP2022177090A5 (cg-RX-API-DMAC7.html)
US20210171611A1 (en) Antibody that binds to envelope glycoprotein of sever fever with thrombocytopenia syndrome virus and use for same
JP2024038003A5 (cg-RX-API-DMAC7.html)
TW202126692A (zh) 抗人Claudin18.2抗體及其應用
JP2024026132A5 (cg-RX-API-DMAC7.html)
AU2025200368A1 (en) Anti-cd3 antibody and molecules comprising the antibody
EP3928790A1 (en) Cd3 antigen binding fragment and application thereof
JP2023545182A5 (cg-RX-API-DMAC7.html)
JP2022533538A5 (cg-RX-API-DMAC7.html)
JP2023093753A5 (cg-RX-API-DMAC7.html)
JP2022534135A5 (cg-RX-API-DMAC7.html)
JP2023545183A5 (cg-RX-API-DMAC7.html)
JP2024540148A5 (cg-RX-API-DMAC7.html)
CN104271602A (zh) 双特异性抗体
JP2021530244A5 (cg-RX-API-DMAC7.html)
CN112574300A (zh) 抗sar-cov-2全人源单克隆抗体及其制法与应用
US20250042991A1 (en) Leptin antibodies and method of reducing leptin
JP2024546759A5 (cg-RX-API-DMAC7.html)
JP2024546763A5 (cg-RX-API-DMAC7.html)
JP2025114620A5 (cg-RX-API-DMAC7.html)
WO2024175093A1 (en) Antibodies, antigen-binding fragments and methods of use
JP2021512652A5 (cg-RX-API-DMAC7.html)
JP2024516098A5 (cg-RX-API-DMAC7.html)
KR20220167331A (ko) 항-flt3 항체 및 조성물
JP2024500512A5 (cg-RX-API-DMAC7.html)